DRG Might Be Good For Listed Healthcare Providers

The healthcare sector has been making headlines recently, with many calling for regulatory and systemic reforms

as insurance premiums are expected to rise by up to 70% next year. As a result, the Health Ministry has proposed that diagnosis-related group pricing system, (DRG) be implemented. Oong Chun Sung, Equity Research Analyst, RHB Investment Bank tells us if DRG will be a boom or bane for earnings and which listed companies stand to benefit.

Image Credits: Shutterstock.com